Latest JOHNSON & JOHNSON Stock Portfolio
$652Million | No. of Holdings #16
JOHNSON & JOHNSON Performance
2026 Q1+18.16%
YTD+18.16%
2025+51.06%
About JOHNSON & JOHNSON and 13F Hedge Fund Stock Holdings
On 2026-05-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, JOHNSON & JOHNSON reported an equity portfolio of $652.4 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of JOHNSON & JOHNSON are PTGX, NBTX, MGTX. The fund has invested 39.6% of it's portfolio in PROTAGONIST THERAPEUTICS INC. and 26.6% of portfolio in NANOBIOTIX S.A. <br><br> The fund managers got completely rid off RALLYBIO CORPORATION (RLYB) and LYELL IMMUNOPHARMA, INC. (LYEL) stocks. They significantly reduced their stock positions in NANO-X IMAGING LTD. (NNOX). JOHNSON & JOHNSON opened new stock positions in RALLYBIO CORPORATION (RLYB).
JOHNSON & JOHNSON Equity Portfolio Value
Last Reported on: 13 May, 2026
$652Million
as of May 13, 2026JOHNSON & JOHNSON Annual Return Estimates Vs S&P 500
Our best estimate is that JOHNSON & JOHNSON made a return of 18.16% in the last quarter. In trailing 12 months, it's portfolio return was 101.59%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| rallybio corporation | 1,371,520 |
New stocks bought by JOHNSON & JOHNSON
Additions
No additions were made to existing positions by JOHNSON & JOHNSON
Reductions
| Ticker | % Reduced |
|---|---|
| nano-x imaging ltd. | -47.4 |
JOHNSON & JOHNSON reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| rallybio corporation | -2,494,910 |
| lyell immunopharma, inc. | -1,689,420 |
JOHNSON & JOHNSON got rid off the above stocks
Sector Distribution
JOHNSON & JOHNSON has about 58% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 58 |
| Others | 42 |
Market Cap. Distribution
JOHNSON & JOHNSON has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
- SMALL-CAP
- MICRO-CAP
| Category | % |
|---|---|
| UNALLOCATED | 42 |
| MID-CAP | 39.6 |
| SMALL-CAP | 11.6 |
| MICRO-CAP | 6.6 |
Stocks belong to which Index?
About 58% of the stocks held by JOHNSON & JOHNSON either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 58 |
| Others | 42 |
JOHNSON & JOHNSON Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of JOHNSON & JOHNSON
JOHNSON & JOHNSON has 16 stocks in it's portfolio. About 99% of the portfolio is in top 10 stocks. LEGN proved to be the most loss making stock for the portfolio. PTGX was the most profitable stock for JOHNSON & JOHNSON last quarter.
$652.36MTotal Value
18.00Positions
13 May, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Adicet Bio, Inc. Adicet Bio, Inc.ACET JOHNSON & JOHNSON's holding in Adicet Bio, Inc. over time | 0.02% | 22,779 | $155.1K 0.02% | 0%unchanged 0 percentunchanged | |
 Cvrx, Inc. Cvrx, Inc.CVRX JOHNSON & JOHNSON's holding in Cvrx, Inc. over time | 5.84% | 4,024,860 | $38.08M 5.84% | 0%unchanged 0 percentunchanged | |
 Fate Therapeutics, Inc. JOHNSON & JOHNSON's holding in Fate Therapeutics, Inc. over time | 0.62% | 3,379,060 | $4.05M 0.62% | 0%unchanged 0 percentunchanged | |
 Standard Biotools, Inc. JOHNSON & JOHNSON's holding in Standard Biotools, Inc. over time | 0.04% | 311,967 | $286.8K 0.04% | 0%unchanged 0 percentunchanged | |
 LEGN Legend Biotech CorporationLegend Biotech CorporationLEGN | 2.26% | 814,586 | $14.74M 2.26% | 0%unchanged 0 percentunchanged | |
 Lyell Immunopharma, Inc. JOHNSON & JOHNSON's holding in Lyell Immunopharma, Inc. over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Meiragtx Holdings Plc JOHNSON & JOHNSON's holding in Meiragtx Holdings Plc over time | 8.82% | 6,641,060 | $57.51M 8.82% | 0%unchanged 0 percentunchanged | |
 NBTX Nanobiotix S.A.Nanobiotix S.A.NBTX | 26.61% | 5,623,820 | $173.61M 26.61% | 0%unchanged 0 percentunchanged | |
 NNOX Nano-X Imaging Ltd.Nano-X Imaging Ltd.NNOX | 0.03% | 83,554 | $189.7K 0.03% | 47.4%decreased 47.4 percentreduced | |
 Procept Biorobotics Corporation JOHNSON & JOHNSON's holding in Procept Biorobotics Corporation over time | 1.37% | 357,939 | $8.95M 1.37% | 0%unchanged 0 percentunchanged | |
 Protagonist Therapeutics Inc. JOHNSON & JOHNSON's holding in Protagonist Therapeutics Inc. over time | 39.57% | 2,449,180 | $258.14M 39.57% | 0%unchanged 0 percentunchanged | |
 Rallybio Corporation JOHNSON & JOHNSON's holding in Rallybio Corporation over time | 0.21% | 152,901 | $1.37M 0.21% | Newnew position | |
Rallybio Corporation JOHNSON & JOHNSON's holding in Rallybio Corporation over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Vor Biopharma, Inc. JOHNSON & JOHNSON's holding in Vor Biopharma, Inc. over time | 0.15% | 53,732 | $958.6K 0.15% | 0%unchanged 0 percentunchanged | |
 Xencor, Inc. Xencor, Inc.XNCR JOHNSON & JOHNSON's holding in Xencor, Inc. over time | 1.38% | 748,062 | $9.02M 1.38% | 0%unchanged 0 percentunchanged | |
Com Rapport Therapeutics, Inc.Rapport Therapeutics, Inc. | 8.56% | 1,784,520 | $55.84M 8.56% | 0%unchanged 0 percentunchanged | |
Cl A Contineum Therapeutics Inc.Contineum Therapeutics Inc. | 3.96% | 1,979,170 | $25.85M 3.96% | 0%unchanged 0 percentunchanged | |
Com Neumora Therapeutics, Inc.Neumora Therapeutics, Inc. | 0.55% | 1,849,440 | $3.61M 0.55% | 0%unchanged 0 percentunchanged | |